Delphia (USA)’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-10,212
| Closed | -$76.3K | – | 162 |
|
|
2023
Q2 | $76.3K | Sell |
10,212
-16,258
| -61% | -$121K | 0.12% | 202 |
|
|
2023
Q1 | $177K | Buy |
+26,470
| New | +$177K | 0.22% | 201 |
|
|
2022
Q3 | – | Sell |
-18,281
| Closed | -$149K | – | 402 |
|
|
2022
Q2 | $149K | Buy |
+18,281
| New | +$149K | 0.1% | 311 |
|